Triple-Negative Breast Carcinoma — Trials

Triple-Negative Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

948 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 416
Recruiting: 234
Ph III recruiting: 21
Growth YoY: +2.4%
Industry share: 31%
Top sponsor: Fudan University
Termination share: 47%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (167)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05686720	Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer	unknown	Early Phase 1	12	First Affiliated Hospital of Shantou University Medical CollegeOTHER	1	Jan 17, 2023	clinicaltrials
NCT05680662	The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism	unknown	Early Phase 1	200	Ministry of Health, Saudi ArabiaOTHER_GOV